NCT00307619View on ClinicalTrials.gov

An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder.

PHASE3CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

April 30, 2005

Conditions
Binge Eating
Interventions
DRUG

topiramate

All Listed Sponsors
lead

Janssen-Cilag Farmaceutica Ltda.

INDUSTRY

NCT00307619 - An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder. | Biotech Hunter | Biotech Hunter